Stage I Triple-Negative Breast Cancer: Melissa's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage I
- Biomarkers
- BRCA-positive carrier status; ER-negative; PR-negative; HER2-negative (triple-negative)
- Sex
- Female
- Treatment
- surgery, chemotherapy and reconstruction
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- Bilateral mastectomy with implant-based reconstruction, including tissue expanders followed by implant exchange → adjuvant chemotherapy.
What happened, in summary
Melissa Berry learned she carried a BRCA gene alteration at age 32 after several women on her mother’s side of the family developed breast cancer. The result initially frightened her, but it also led to intensive screening with MRI, mammography and ultrasound every 6 months.
Ten years later, at 42, Melissa went for a routine mammogram shortly after a clear MRI. During the clinical examination, a technician felt a tiny, pea-sized lump in her left breast. The mammogram did not show a clear mass, but a physician noticed a shadow and insisted on a deeper needle biopsy. The biopsy found stage 1 triple-negative breast cancer. Melissa had no lymph-node involvement.
She chose a bilateral mastectomy followed by implant reconstruction. Tissue expanders were placed first and later exchanged for implants. Surgery came before chemotherapy. Treatment brought fatigue, appetite changes, hair and eyelash loss, and a difficult emotional adjustment.
At the time of the interview, Melissa was a 10-year survivor and described herself as having no evidence of disease. She continued annual oncology follow-up and had become a full-time advocate, creating Cancer Fashionista and supporting the Triple Negative Breast Cancer Foundation. She credited genetic testing and consistent surveillance with finding the cancer when it was still small and highly treatable.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer